What's New on the FDA Drugs Site
August 1, 2017
- Antibacterial Therapies for Patients With an Unmet Medical Need for the Treatment of Serious Bacterial DiseasesGuidance for Industry (PDF - 149KB)
- FDA approves Idhifa (enasidenib), a new targeted treatment for relapsed or refractory acute myeloid leukemia
- FDA Drug Shortages
- Dexrazoxane Injection (Updated - Currently in Shortage)
- Tolmetin Sodium Tablets, USP (Updated - Currently in Shortage)
- Medication Guides Page (Updated)
.png)
No hay comentarios:
Publicar un comentario